logo
2026 ICD-10-CM Changes

Coding

2026 ICD-10-CM Changes

Date Posted: Wednesday, November 26, 2025

 

Effective October 1, 2025, the 2026 ICD-10-CM update is live, with 480+ new codes, 38 revisions, and 28 deletions. The focus this year: sharper clinical detail, clearer guidance around genetics and social determinants of health (SDOH), and better data specificity for patient care and reimbursement.

 

Why this update matters:

 

  • Greater clinical specificity and laterality
  • Expanded recognition of genetic/hereditary conditions
  • Better capture of SDOH
  • Coding pathways for emerging diseases/treatments

 

Guideline Updates You'll Use Every Day

 

“Multiple sites” clarified:

 

  • If documentation specifies each involved site, code each site separately.
  • Use a “multiple sites” code only when the provider does not specify individual locations.

 

HIV coding (B20, Z21, R75) refined:

 

  • B20: Use for HIV disease/AIDS or any HIV-related condition; once assigned, use B20 permanently.
  • Z21: Asymptomatic HIV positive.
  • R75: Inconclusive serology.
  • Pregnancy: Sequence pregnancy codes first, then HIV status.
  • New: Z29.81 for PrEP (pre-exposure prophylaxis) encounters.

 

New: Type 2 diabetes in remission:

 

  • E11.A distinguishes true remission from “resolved/controlled.”
  • Requires explicit provider wording: “in remission.”

 

Hypertension + heart disease linkage:

 

  • If documentation links HTN with heart conditions (e.g., heart failure, myocarditis), assign I11- codes.
  • If clearly unrelated, code separately. Rely on provider documentation—avoid assumptions.

 

Notable Code Set Changes (By Area)

 

Infectious diseases:

 

  • Expanded HIV-related conditions.
  • New detail for Demodex mite infestation.

 

Neoplasms:

 

  • New codes for inflammatory breast cancers.
  • Includes laterality and research-aligned categories.

 

Blood and endocrine:

 

  • Abnormal autoantibody findings (e.g., rheumatoid factor, anti-CCP) without clinical RA.
  • Hyperoxaluria now broken out (primary, secondary, dietary-related).
  • Familial hypercholesterolemia split into homozygous vs heterozygous.
  • Lipodystrophy subtypes, including HIV-associated.

 

Neurology and genetics:

 

  • Multiple sclerosis: relapsing vs progressive, active/inactive status.
  • Primary apraxia of speech: new code supports neuro/speech data capture.
  • Limb-girdle muscular dystrophy: genetic-specific expansion.

 

Eyes/ears and congenital:

 

  • Thyroid eye disease and secondary angle-closure glaucoma now laterality-specific.
  • Usher syndrome type-specific codes.
  • New codes for syndromes such as Kabuki, CTNNB1, Howell Foundation, and others.
  • Neurodevelopmental disorders reflect specific gene variants (e.g., FOXG1, DLG4, SLC6A1).

 

Skin and ulcers:

 

  • Chronic non-pressure ulcers (abdomen, face, arms, groin) now severity-specific.
  • New codes for abscesses, contusions, puncture wounds of flank/groin/abdominal wall.

 

Pain and lab findings:

 

  • Expanded abdominal and flank pain with laterality.
  • R11.16: Cannabis hyperemesis syndrome.
  • Costovertebral angle tenderness added.
  • Codable abnormal immunologic labs even without a definitive diagnosis.

 

External causes and SDOH:

 

  • New external-cause detail (e.g., fishing-hook piercings, sharp objects via orifices).
  • Additions for Gulf War illness/war-related exposures.
  • Clearer capture of prophylactic surgeries (even without family history).
  • New Z codes for financial insecurity and utility access.

 

Action Checklist for Coding Leaders

 

To comply with the recent changes, be sure to:

 

  • Update charge masters, problem lists, EHR pick-lists, and templates.
  • Educate providers to use phrases like “in remission,” site-specific detail, and explicit HTN-heart links.
  • Tune CDI queries for HIV status, diabetes remission, “multiple sites,” and ulcer severity.
  • Audit hot spots early (HIV status sequencing, E11.A use, I11- linkage, SDOH Z-codes).
  • Refresh training: Share quick guides and example notes that meet new specificity.

 

Quick reminders:

 

  • Once B20, always B20.
  • E11.A requires documented remission—not just “controlled.”
  • Don't default to “multiple sites” when documentation lists distinct locations.
  • Use SDOH Z-codes when clearly documented and relevant to care.

 

Bottom Line

 

2026 continues the push toward precision. Pair clear provider documentation with the new options (remission, genetic variants, SDOH, laterality/severity) to protect reimbursement and improve data quality.

 

BC Advantage Magazine: BC Advantage is the largest independent resource provider in the industry for Medical Coders, Medical Billers, Healthcare Auditors, Practice Managers, Compliance Officers, and Documentation Experts.

 

 

Was this article helpful?

Your feedback goes directly to our editorial team and helps us decide what to cover next.

Memory used: 3.29 MB